# Leuprorelin Acetate

## Eligard inj 22.5mg extended-release

| TAH Drug Code      | [IELI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IELI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For the palliative treatment of advanced prostate cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | Eligard 22.5mg is administered subcutaneously every 3 months. The injection provides continuous release of leuprolide acetate over the treatment period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Patients with hypersensitivity to GnRH, GnRH agonist analogs, or any of the components of ELIGARD. Women and pediatric patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Common Cardiovascular: Edema (Adults, 8.2% to 20.8% ) Dermatologic: Acne (Endometriosis 10% ), Flushing (Central precocious puberty, 5% ; prostate cancer, 52% to 73.3% ), Injection site disorder (Central precocious puberty, 9% ; prostate cancer, 8.2% to 37.5% ), Injection site pain (Central precocious puberty, 19% to 31% ; prostate cancer, 19.2% ), Rash (Central precocious puberty, 3% ; prostate cancer, 6% ) Endocrine metabolic: Increased testosterone level, Transient, Serum triglycerides raised (Endometriosis, 12% to 32% ), Weight increased (Central precocious puberty, 7% ) Gastrointestinal: Abdominal pain (Central precocious puberty, 9% ), Constipation (Central precocious puberty, 6% ; prostate cancer, 9.9% ), Nausea (Central precocious puberty, 8% ), Nausea and vomiting (Endometriosis, 13% to 29%; uterine fibroids, 4.8% to 5% ), Vomiting (Central precocious puberty, 6% ) Hematologic: Anemia (Prostate cancer, 2.3% to 6.6% ) Musculoskeletal: Arthralgia (Prostate cancer, 9.3% ), Arthropathy (Prostate cancer, 4.2% to 16.3% ), Decreased bone mineral density, Myalgia (Prostate cancer, 7.9% ) Neurologic: Asthenia (Prostate cancer, 12.2% ; uterine fibroids, 8% to 18% ), Dizziness (Endometriosis, 11% ; uterine fibroids, 1.8% ), Headache (Central precocious puberty, 2% to 16% ; endometriosis, 32% ; prostate cancer, 4.2% ), Insomnia, Lethargy Psychiatric: Mood swings (Central precocious puberty, 2% to 5% ) Renal: Dysuria (6% ) Reproductive: Atrophy of testis (Prostate cancer, 4.4% to 20.2% ), Vaginitis (Endometriosis, 8% to 28%; uterine fibroids, 11% to 11.4% ) Respiratory: Bronchospasm (Central precocious puberty, 6% ), Cough (Central precocious puberty, 13% prostate cancer, 6.6% ), Nasopharyngitis (Central precocious puberty, 22% ), Productive cough (Central precocious puberty, 6% ) Other: Fever (Central precocious puberty, 17% ), Malaise and fatigue (Prostate cancer, 6% to 17.5% ), Pain (Central precocious puberty, 3% ; endometriosis, 19% to 29% ; prostate cancer, 4.2% to 32.7% ; uterine fibroids, 8% to 6.1% ) Serious Cardiovascular: Heart failure (Adults, less than 5% ), Myocardial infarction, Prolonged QT interval Hepatic: Injury of liver Musculoskeletal: Fracture of vertebral column Neurologic: Fracture of vertebral column, Pseudotumor cerebri, Seizure (Prostate cancer, less than 0.5% ) Psychiatric: Depression (Up to 5% ), Suicidal thoughts Respiratory: Pulmonary embolism |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/leuprorelin-acetate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Leuplin Depot 1M inj 3.75mg

| TAH Drug Code      | [ILEU3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ILEU3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Palliative treatment of prostate cancer, treatment of endometriosis, treatment of pediatric patients with central precocious puberty, anemia (uterine leiomyoma or preoperatively with iron therapy), premenopausal breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | [Endometriosis] 3.75 mg subcutaneously once every 4 weeks, with the first injection given on days 1-5 of menstruation. Treatment duration is recommended for 6 months. [Uterine fibroids causing excessive menstrual bleeding and anemia, scheduled for surgical removal] Recommended treatment duration is up to 3 months. 1.88-3.75mg subcutaneously every 4 weeks, with the first injection given on days 1-5 of menstruation. [Prostate cancer and Premenopausal breast cancer] 3.75 mg subcutaneously once every 4 weeks. [Central precocious puberty] For body weight < 20 kg: 1.88-3.75 mg; for body weight >= 20 kg: 3.75-7.5 subcutaneously once every 4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity to leuprolide, gonadotropin releasing hormone (GnRH), GnRH agonists or any of the excipients in the formulations. Pregnancy. Undiagnosed and abnormal uterine bleeding.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common: Edema (Adults, 8.2-20.8%), Acne (Endometriosis 10%), Flushing (Central precocious puberty, 5% ; prostate cancer, 52-73.3%), Hyperhidrosis (Central precocious puberty, 4%), Injection site disorder (Central precocious puberty, 9-78% ; prostate cancer, 8.2-37.5%), Injection site pain (Central precocious puberty, 19-31% ; prostate cancer, 19.2%), Rash (Central precocious puberty, 3-7% ; prostate cancer, 6%), Serum triglycerides above reference range (Endometriosis, 12-32%), Testosterone level above reference range, Transient, Weight increased (Central precocious puberty, 7%), Abdominal pain (Central precocious puberty, 9-18%), Constipation (Central precocious puberty, 6% ; prostate cancer, 9.9%), Nausea (Central precocious puberty, 8%), Nausea and vomiting (Central precocious puberty, 13% ; endometriosis, 13-29%; uterine fibroids, 4.8-5%), Vomiting (Central precocious puberty, 6%), Anemia (Prostate cancer, 2.3-6.6%), Arthralgia (Prostate cancer, 9.3%), Arthropathy (Prostate cancer, 4.2-16.3%), Backache (Central precocious puberty, 7%), Decreased bone mineral density, Fracture of bone (Central precocious puberty, 4%), Myalgia (Prostate cancer, 7.9%), Pain in limb (Central precocious puberty, 9%), Sprain of ligament (Central precocious puberty, 7%), Asthenia (Prostate cancer, 12.2% ; uterine fibroids, 8-18%), Dizziness (Endometriosis, 11% ; uterine fibroids, 1.8%), Headache (Central precocious puberty, 2-33% ; endometriosis, 32% ; prostate cancer, 4.2%), Insomnia (Central precocious puberty, 4%), Lethargy, Mental disorder (Central precocious puberty, 22%), Mood swings (Central precocious puberty, 2-5%), Dysuria, Atrophy of testis (Prostate cancer, 4.4-20.2%), Breast tenderness (4%), Vaginitis (Endometriosis, 8-28%; uterine fibroids, 11-11.4%), Bronchospasm (Central precocious puberty, 6%), Cough (Central precocious puberty, 13% prostate cancer, 6.6%), Nasopharyngitis (Central precocious puberty, 22%), Productive cough (Central precocious puberty, 6%), Chest pain (Central precocious puberty, 4%), Fever (Central precocious puberty, 13-17%), Malaise and fatigue (Prostate cancer, 6-17.5%), Pain (Central precocious puberty, 3% ; endometriosis, 19-29% ; prostate cancer, 4.2-32.7% ; uterine fibroids, 8-6.1%) Serious: Heart failure (Adults, <5%), Myocardial infarction, Prolonged QT interval, Injury of liver, Fracture of vertebral column, Pseudotumor cerebri, Seizure (Prostate cancer, <0.5%), Depression (Up to 5%), Suicidal thoughts, Pulmonary embolism |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/leuprorelin-acetate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

